Introduction Burnout among healthcare professionals remains a critical public health issue linked to impaired cognition, emotional exhaustion and diminished clinical performance. Structured breathing ...

Highlights: First participant enrolled and dosed with NUZ-001 in Regimen I of the HEALEY ALS Platform Trial evaluating ...

NEW YORK, NY, UNITED STATES, February 25, 2026 /EINPresswire.com/ -- Peep Nation Health, a leader in natural metabolic ...

Researchers at The Hospital for Sick Children (SickKids), working with international collaborators and youth and family ...

In paediatrics, “more trials have been done over the last ten years, but we have struggled with transparency and clarity, and sometimes with the quality because they are not always asking the ...

Alps Group Inc (the “Company” or “Alps Group”), the parent company of Alps Life Sciences Inc. (“Alps Holdco”), a fully integrated biotechnology research and healthcare platform specializing in ...

Diversity in clinical trials matters for drug safety and efficacy—and for future medical advancements. Clinical trial ...

Discover how TMS therapy targets depression at the source. A deep dive into the physics, safety protocols, and FDA-cleared ...

Patients with ischemic stroke whose door-in-door-out times exceeded 90 minutes had lower odds for endovascular therapy and ...

Introduction Dyspnoea is an existentially burdensome symptom in patients with advanced and progressive diseases such as cancer, chronic obstructive pulmonary disease (COPD) and advanced heart failure.

The FDA approved protocol updates to a tasquinimod trial in myelofibrosis, allowing broader enrollment and combination use with JAK inhibitors.

Early studies suggest that virtual reality may expand access to psychosexual care, but small trials highlight the need for larger controlled studies before routine clinical use.